Hypersomnia
Hypersomnia is a condition in which you feel excessive sleepiness during the day. It may occur even after long stretches of sleep. Another name for hypersomnia is excessive daytime sleepiness (EDS). Hypersomnia can be a primary condition or a secondary condition.
Cluster Number:
Wiki Number: W098
Diagnosis: Hypersomnia
US Patients: 5-10%
World Patients:
Sex Ratio: M+;W
Age Onset:
Brain Area:
Symptoms: lack of alertness in daytime; prolonged night sleep for 3 months;sleep drunkenness-difficulty waking up;
Progression: Most other major diseases have hypersomnias and inability to have refreshing delta sleep at night.
Causes: narcolepsy, sleep apnea, reaction to medications,
Medications: modafinil is helpful.
Therapies: Using beds only for sleep and sex helps.
Youtube Video: Breakthroughs in the Management of
Idiopathic Hypersomnia
Amazon or Library Book: A Guide: How to Focus and be productive with oversleeping
Click the text to link or order from Amazon.
Support Group: hypersomniaalliance.com; 678-842-3512 (hypersomniafoundation.org)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Depression in High-Risk Offspring: The Mediating Role of Sleep Problemsby Hannah A Roberts on January 20, 2025
Parental depression is associated with offspring depression and sleep problems are prospectively associated with the development of depression. However, little work has examined sleep problems in the offspring of depressed parents and whether these problems partially account for the association between parent and offspring depression. This longitudinal study examined the indirect effect of sleep problems on the association between parent psychopathology and offspring depression in a sample of...
- Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting systemby Qineng Gong on January 17, 2025
CONCLUSION: This study identified several new adverse event signals for maribavir, offering healthcare professionals a deeper understanding of its safety profile, which may guide safer clinical usage.
- A roadmap toward promoting and improving brain health in Europe and closing the awareness and funding gapby Paul A J M Boon on January 16, 2025
CONCLUSIONS: The paper highlights the importance of a unified approach, integrating international collaborations and local initiatives, to improve BH outcomes based on the WHO-iGAP, and support sustainable development goals, in particular SDG 3: Good Health and Well-being and SDG 4: Quality Education.
- Central nervous system involvement in Whipple's disease: Report of a rare pathological entity and comparative review of treatment strategies and outcomesby Moustafa A Mansour on January 14, 2025
Whipple's disease, caused by the gram-positive actinomycete Tropheryma whipplei, is a rare chronic systemic illness with significant diagnostic and therapeutic challenges, particularly when the CNS is involved. This case report details a 46-year-old man presenting with a constellation of symptoms including fatigue, hypersomnia, weight loss, bifrontal headaches, abdominal pain, treatment-unresponsive diarrhea, and skin hyperpigmentation. Neurological examination revealed oculomasticatory...